7.94 USD
↘ 0.75 (8.69%)PRE MARKET (AS OF 04:02 AM EDT)
REGENXBIO Inc.
RGNXNASDAQ • USD
Market: OPEN
RGNX is currently priced at $7.94. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, RGNX trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Sep 15, 2026.
Open?$7.94
High?$7.94
Low?$7.94
Prev. Close?$8.69
Volume?18
Avg. Volume?1.3M
VWAP?$7.94
Rel. Volume?0.00x
Bid / Ask
Bid?$6.69 × 100
Ask?$9.00 × 100
Spread?$2.31
Midpoint?$7.85
Valuation & Ratios
Market Cap?524.8M
Shares Out?66.0M
Float?51.7M
Float %?78.4%
P/E Ratio?N/A
P/B Ratio?7.31
EPS?-$2.98
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
Themes
Employees
371
Market Cap
573.7M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2015-09-17
Address
9804 MEDICAL CENTER DRIVE
ROCKVILLE, MD 20850
Phone: 240-552-8181
ROCKVILLE, MD 20850
Phone: 240-552-8181
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?0
Momentum?62
Short Sent.?45
Piotroski F-Score?4/9Mixed
Altman Z-Score?-3.79Distress
Confidence?58%Low
Short InterestHigh
Short % of Float?14.50%High
Short Interest?7.5M
Days to Cover?4.9
Free Float51.7M
Avg Daily Volume1.5M
Settlement Date2026-08-31
Financial Health
Current Ratio?2.86Strong
Quick Ratio?2.86Strong
Cash Ratio?0.44Low
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?7.31FAIR▾
Peers100
S&P26
P/S?3.01FAIR▾
Peers100
S&P50
P/FCF?N/A▾
EV/EBITDA?-3.3CHEAP▾
S&P97
EV/Sales?2.80CHEAP▾
Peers100
S&P63
Returns & Efficiency
ROE?-273.7%WEAK▾
S&P3
ROA?-50.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-249668000
Enterprise Value?$488.3M
Fundamentals ratios updated end of day